EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
EnPlusOne Biosciences has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2025.
EnPlusOne Biosciences's investors include Coatue, Breakout Ventures, Northpond Ventures.
EnPlusOne Biosciences is headquartered in Watertown, United States.
EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
EnPlusOne Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EnPlusOne Biosciences — Funding & Investors." VCBacked, February 19, 2025, https://www.vcbacked.co/company/enplusone-biosciences. Accessed November 12, 2026.
VCBacked. (2025). EnPlusOne Biosciences — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/enplusone-biosciences
{{cite web |title=EnPlusOne Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/enplusone-biosciences |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at EnPlusOne Biosciences? Request a listing update